Market Tracker

10/24 6:05pm ET

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

11.71
Data as of Oct 24
 +0.49 / +4.37%
Today’s Change
2.26
Today|||52-Week Range
13.80
+252.82%
Year-to-Date

Today’s Trading

Previous close11.22
Today’s open11.21
Day’s range11.16 - 11.74
Volume4,116,574
Average volume (3 months)6,131,599
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)+1.56%
Earnings growth (this year)-12.52%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book7.41

Competitors

 Today’s
change
Today’s
% change
KPTIKaryopharm Therapeut...+0.60+1.71%
LGNDLigand Pharmaceutica...-0.16-0.30%
CMRXChimerix Inc+0.84+2.62%
USNAUSANA Health Science...+0.40+0.47%
Data as of 4:02pm ET, 10/24/2014

Financials

Next reporting dateNovember 11, 2014
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$0.00
Annual profit (last year)-$58.9M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Secretary, EVP &
Investor Relations Contact
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts